CB1 receptor and psychosis: friend, foe, or both.
Saved in:
| Title: | CB1 receptor and psychosis: friend, foe, or both. |
|---|---|
| Authors: | Rao JS; IGC Pharma Inc, Potomac, MD, United States., Tangarife MA; IGC Pharma Inc, Potomac, MD, United States., Rodríguez-Soacha DA; IGC Pharma Inc, Potomac, MD, United States., Mukunda R; IGC Pharma Inc, Potomac, MD, United States. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2025 Jul 22; Vol. 16, pp. 1630080. Date of Electronic Publication: 2025 Jul 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40766927 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CB1 receptor and psychosis: friend, foe, or both. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rao+JS%22">Rao JS</searchLink>; IGC Pharma Inc, Potomac, MD, United States.<br /><searchLink fieldCode="AU" term="%22Tangarife+MA%22">Tangarife MA</searchLink>; IGC Pharma Inc, Potomac, MD, United States.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Soacha+DA%22">Rodríguez-Soacha DA</searchLink>; IGC Pharma Inc, Potomac, MD, United States.<br /><searchLink fieldCode="AU" term="%22Mukunda+R%22">Mukunda R</searchLink>; IGC Pharma Inc, Potomac, MD, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101545006%22">Frontiers in psychiatry</searchLink> [Front Psychiatry] 2025 Jul 22; Vol. 16, pp. 1630080. <i>Date of Electronic Publication: </i>2025 Jul 22 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101545006 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-0640 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216640640%22">16640640 </searchLink><i>NLM ISO Abbreviation: </i>Front Psychiatry <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40766927 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fpsyt.2025.1630080 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1630080 Titles: – TitleFull: CB1 receptor and psychosis: friend, foe, or both. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rao JS – PersonEntity: Name: NameFull: Tangarife MA – PersonEntity: Name: NameFull: Rodríguez-Soacha DA – PersonEntity: Name: NameFull: Mukunda R IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 07 Text: 2025 Jul 22 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1664-0640 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in psychiatry Type: main |
| ResultId | 1 |